/
PRBCF
$0.18+$0.03 (+20.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.15 – $0.24
33% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-1.22
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $67.6M | $91.9M | $92.3M | $83.3M | $91.0M | $75.1M | $86.9M | $77.6M |
| Cost of revenue | $10.0M | $12.5M | $14.6M | $19.8M | $26.0M | $27.2M | $23.8M | $21.1M |
| Gross profit | $57.6M | $79.5M | $77.8M | $63.5M | $65.0M | $47.8M | $63.1M | $56.5M |
| Gross margin | 85.2% | 86.4% | 84.2% | 76.3% | 71.5% | 63.7% | 72.6% | 72.8% |
| R&D | $33.5M | $35.8M | $35.9M | $28.2M | $34.9M | $32.1M | $27.0M | $27.2M |
| Operating income | −$20.0M | $651.0K | −$5.8M | −$14.1M | −$20.0M | −$26.5M | −$9.4M | −$17.1M |
| EBITDA | −$19.2M | $3.6M | −$3.3M | −$9.3M | −$1.0M | −$1.7M | −$5.7M | $3.1M |
| Net income | −$20.5M | $1.0M | −$12.2M | −$13.4M | −$22.2M | −$26.4M | −$8.4M | −$19.9M |
| Net margin | -30.2% | 1.1% | -13.2% | -16.1% | -24.4% | -35.2% | -9.7% | -25.6% |
| EPS (diluted) | -0.50 | 0.02 | -0.29 | -0.32 | -0.47 | -0.40 | -0.11 | -0.25 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $80M | $0.02 | $0.02–$0.02 | 1 |
| 2027 | $115M | $0.04 | $0.04–$0.04 | 1 |
| 2028 | $160M | $0.07 | $0.07–$0.07 | 1 |
| 2029 | $227M | $0.08 | $0.08–$0.08 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
PRECISE BIOMETRICS AB
PRECISE BIOMETRICS AB
Held by traders on TradeandTell
No one on the platform currently holds PRBCF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PRBCF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2022-06-09 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded PRBCF yet.